FEMSelect has designed a minimally-invasive, meshless system for anchoring sutures to ligaments of the pelvic floor for uterine prolapse surgical procedures.
Location: United States, Delaware, Newark
Total raised: $9M
Investors 6
| Date | Name | Website |
| 09.07.2021 | Robin Hood... | robinhoodv... |
| 21.05.2021 | Mid Atlant... | bioangels.... |
| - | Triventure... | triventure... |
| - | New Age Ve... | newagevent... |
| - | New York A... | newyorkang... |
| - | RAD Biomed | radbiomed.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.10.2022 | Series B | $9M | TransPacif... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 22.10.2022 | Israel-based women’s health startup FEMSelect raises USD 9 m... | TEL AVIV, Israel, Oct. 19, 2022— FEMSelect, the creator of EnPlace®, a minimally invasive, meshless ... | vcbay.news... |
| 20.10.2022 | FEMSelect raises $9M to expand its pelvic floor fixation dev... | The company will continue to expand in the US to enable more women to access its EnPlace device Pel... | vator.tv/n... |
| 20.10.2022 | FEMSelect Raises US$9M in Series B Financing | FemSelect, a Tel Aviv, Israel-based developer of an innovative approach to pelvic floor ligament fix... | finsmes.co... |
| - | FEMSelect | “FEMSelect has designed a minimally-invasive, meshless system for anchoring sutures to ligaments of ... | fastfounde... |